Cell-based assays have the potential to deliver more information about intracellular molecular targets than conventional methods such as molecular manipulation and random screening. These assays are critical tools for studying cellular mechanisms in a biological context. A variety of cell-based assays are available in the market that cover applications such as cellular functions assessment, toxicity studies, and processes in biological research. The global cell-based assay market accounted for $3,625 million in 2016, and is anticipated to reach $10,618 million by 2023, registering a CAGR of 16.5% from 2017 to 2023.... Research Beam Model: Research Beam Product ID: 2139705 5370 USD New
Cell-based Assay Market by Product (Consumable, Instrument, Service, and Software), Application (Drug Discovery; Basic Research; Absorption, Distribution, Metabolism, & Excretion (ADME) Studies; Predictive Toxicology; and Others), and End User (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, Contract Research Organizations, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Cell-based Assay Market by Product (Consumable, Instrument, Service, and Software), Application (Drug Discovery; Basic Research; Absorption, Distribution, Metabolism, & Excretion (ADME) Studies; Predictive Toxicology; and Others), and End User (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, Contract Research Organizations, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

 
  • Category : Diagnostic and Biotech
  • Published On : September  2017
  • Pages : 260
 
 

Cell-based assays have the potential to deliver more information about intracellular molecular targets than conventional methods such as molecular manipulation and random screening. These assays are critical tools for studying cellular mechanisms in a biological context. A variety of cell-based assays are available in the market that cover applications such as cellular functions assessment, toxicity studies, and processes in biological research. The global cell-based assay market accounted for $3,625 million in 2016, and is anticipated to reach $10,618 million by 2023, registering a CAGR of 16.5% from 2017 to 2023.

Rise in adoption of high-throughput screening methods and surge in preference of cell-based assays boost the market growth. In addition, increase in availability of funds for R&D and innovation, and increase in drug delivery activity supplement the growth further. However, high costs associated with equipment and standardization concerns in cell-based assay methods impede the market growth. Furthermore, increase in adoption of label-free cell-based assays and the untapped emerging countries offer lucrative opportunities for market development.

The global cell-based assay market is segmented based on product, application, end user, and geography. Based on product, it is divided into consumable, instrument, service, and software. The consumables segment is further classified into reagents, microplates, probes & labels, assay kits, cell lines, and others. Assay kit segment includes reporter gene assays, cell growth assays, second messenger assays, cell death assays, and others. The cell line segment is divided into immortalized cell lines, primary cell lines, and stem cell lines. Based on application, the market is categorized into drug discovery; basic research; absorption, distribution, metabolism, & excretion (ADME) studies; predictive toxicology; and others. On the basis of end user, it is categorized into pharmaceutical & biotechnology companies, academic & government research institutes, contract research organizations, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The report provides a comprehensive analysis of the key players that operate in the global cell-based assay market.

KEY PLAYERS PROFILED

  • Becton, Dickinson and Company
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.
  • General Electric Company
  • Merck KGaA
  • Perkinelmer, Inc.
  • Bio-Rad Laboratories, Inc.
  • Lonza Group Ltd.
  • Cell Signaling Technology, Inc.
  • Promega Corporation

KEY MARKET BENEFITS

  • The study provides an in-depth analysis of the global cell-based assay market and the current trends and future estimations to elucidate the imminent investment pockets.
  • It presents quantitative analysis of the market from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on product assists to understand the trends in the industry.
  • Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the industry.

KEY MARKET SEGMENTS

By Product

  • Consumable
    • Reagents
    • Microplates
    • Probes & Labels
    • Assay Kits
      • Reporter Gene Assays
      • Cell Growth Assays
      • Second Messenger Assays
      • Cell Death Assays
      • Others
    • Cell Lines
      • Immortalized Cell Lines
      • Primary Cell Lines
      • Stem Cell Lines
    • Other Consumables
  • Instrument
  • Service
  • Software

By Application

  • Drug Discovery
  • Basic Research
  • ADME Studies
  • Predictive Toxicology
  • Others

By End User    

  • Pharmaceutical & Biotechnology Companies
  • Academic & Government Research Institutes
  • Contract Research Organizations
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Taiwan
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

The other players in the value chain include (profiles not included in the report):

  • Macrogen, Inc.
  • New England Biolabs, Inc.
  • Cisbio Bioassays
  • Cell Biolabs, Inc.
  • DiscoverX Corporation

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PATENTS ANALYSIS

3.3.1. Patent analysis by year
3.3.2. Patent analysis by region

3.4. PORTERS FIVE FORCES ANALYSIS
3.5. MARKET SHARE ANALYSIS

3.5.1. Cell-based assay market share (2012-2017)

3.6. MARKET DYNAMICS

3.6.1. Drivers
3.6.2. Restraints
3.6.3. Opportunities

CHAPTER 4 GLOBAL CELL-BASED ASSAY MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size & forecast

4.2. CONSUMABLES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size & forecast
4.2.4. Reagents

4.2.4.1. Market size & forecast

4.2.5. Microplates

4.2.5.1. Market size and forecast

4.2.6. Probes & Labels

4.2.6.1. Market size & forecast

4.2.7. Assay Kits

4.2.7.1. Market size & forecast

4.2.8. Cell Lines

4.2.8.1. Market size & forecast

4.2.9. Other Consumables

4.2.9.1. Market size & forecast

4.3. INSTRUMENTS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size & forecast

4.4. SOFTWARE

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size & forecast

4.5. SERVICES

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size & forecast

CHAPTER 5 GLOBAL CELL-BASED ASSAY MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size & forecast

5.2. DRUG DISCOVERY

5.2.1. Market size & forecast

5.3. BASIC RESEARCH

5.3.1. Market size & forecast

5.4. ADME STUDIES

5.4.1. Market size & forecast

5.5. PREDICTIVE TOXICOLOGY

5.5.1. Market size & forecast

5.6. OTHER APPLICATIONS

5.6.1. Market size & forecast

CHAPTER 6 GLOBAL CELL-BASED ASSAY MARKET, BY END USERS

6.1. OVERVIEW

6.1.1. Market size & forecast

6.2. PHARMACEUTICAL COMPANIES

6.2.1. Market size & forecast

6.3. ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES

6.3.1. Market size & forecast

6.4. BIOTECHNOLOGY COMPANIES

6.4.1. Market size & forecast

6.5. OTHER END USERS

6.5.1. Market size & forecast

CHAPTER 7 GLOBAL CELL-BASED ASSAY MARKET, BY GEOGRAPHY

7.1. OVERVIEW

7.1.1. Market size & forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size & forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size & forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size & forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. South Korea market size and forecast
7.4.3.6. Taiwan market size and forecast
7.4.3.7. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size & forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. Turkey market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1. BECTON DICKINSON AND COMPANY

8.1.1. Operating business segments
8.1.2. Business performance

8.2. THERMO FISHER SCIENTIFIC, INC

8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments

8.3. DANAHER CORPORATION,

8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments

8.4. GENERAL ELECTRIC COMPANY

8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments

8.5. MERCK KGAA

8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments

8.6. PERKINELMER, INC

8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments

8.7. BIO-RAD LABORATORIES, INC.

8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments

8.8. LONZA GROUP LTD

8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments

8.9. CELL SIGNALING TECHNOLOGY, INC.

8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments

8.10. PROMEGA CORPORATION

8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL CELL-BASED ASSAY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 2. GLOBAL CELL-BASED ASSAY CONSUMABLES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 3. CELL-BASED ASSAY CONSUMABLES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 4. CELL-BASED ASSAY MARKET FOR REAGENTS, BY REGION, 2016-2023 ($MILLION)
TABLE 5. CELL-BASED ASSAY MARKET FOR MICROPLATES, BY REGION, 2016-2023 ($MILLION)
TABLE 6. CELL-BASED ASSAY MARKET FOR PROBES AND LABELS, BY REGION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL CELL-BASED ASSAY MARKET FOR ASSAY KITS, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 8. CELL-BASED ASSAY MARKET FOR ASSAY KITS, BY REGION, 2016-2023 ($MILLION)
TABLE 9. GLOBAL CELL-BASED ASSAY MARKET FOR CELL LINES, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 10. CELL-BASED ASSAY MARKET FOR CELL LINES, BY REGION, 2016-2023 ($MILLION)
TABLE 11. CELL-BASED ASSAY MARKET FOR OTHER CONSUMABLES, BY REGION, 2016-2023 ($MILLION)
TABLE 12. CELL-BASED ASSAY INSTRUMENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 13. CELL-BASED ASSAY SOFTWARE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 14. CELL-BASED ASSAY SERVICES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 15. GLOBAL CELL-BASED ASSAY MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 16. DRUG DISCOVERY CELL-BASED ASSAY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 17. BASIC RESEARCH CELL-BASED ASSAY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 18. ADME STUDIES CELL-BASED ASSAY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 19. PREDICTIVE TOXICOLOGY CELL-BASED ASSAY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 20. OTHER APPLICATIONS CELL-BASED ASSAY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 21. GLOBAL CELL-BASED ASSAY MARKET, BY END USERS, 2016-2023 ($MILLION)
TABLE 22. PHARMACEUTICAL COMPANIES CELL-BASED ASSAY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 23. ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES CELL-BASED ASSAY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 24. BIOTECHNOLOGY COMPANIES CELL-BASED ASSAY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 25. OTHER END-USERS CELL-BASED ASSAY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 26. CELL-BASED ASSAY MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 27. NORTH AMERICA CELL-BASED ASSAY MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 28. NORTH AMERICA CELL-BASED ASSAY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 29. NORTH AMERICA CELL-BASED ASSAY CONSUMABLES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 30. NORTH AMERICA CELL-BASED ASSAY MARKET FOR ASSAY KITS, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 31. NORTH AMERICA CELL-BASED ASSAY MARKET FOR CELL LINES, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 32. NORTH AMERICA CELL-BASED ASSAY MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 33. NORTH AMERICA CELL-BASED ASSAY MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 34. EUROPE CELL-BASED ASSAY MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 35. EUROPE CELL-BASED ASSAY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 36. EUROPE CELL-BASED ASSAY CONSUMABLES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 37. EUROPE CELL-BASED ASSAY MARKET FOR ASSAY KITS, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 38. EUROPE CELL-BASED ASSAY MARKET FOR CELL LINES, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 39. EUROPE CELL-BASED ASSAY MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 40. EUROPE CELL-BASED ASSAY MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 41. ASIA-PACIFIC CELL-BASED ASSAY MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 42. ASIA-PACIFIC CELL-BASED ASSAY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 43. ASIA-PACIFIC CELL-BASED ASSAY CONSUMABLES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 44. ASIA-PACIFIC CELL-BASED ASSAY MARKET FOR ASSAY KITS, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 45. ASIA-PACIFIC CELL-BASED ASSAY MARKET FOR CELL LINES, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 46. ASIA-PACIFIC CELL-BASED ASSAY MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 47. ASIA-PACIFIC CELL-BASED ASSAY MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 48. LAMEA CELL-BASED ASSAY MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 49. LAMEA CELL-BASED ASSAY MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 50. LAMEA CELL-BASED ASSAY CONSUMABLES MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 51. LAMEA CELL-BASED ASSAY MARKET FOR ASSAY KITS, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 52. LAMEA CELL-BASED ASSAY MARKET FOR CELL LINES, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 53. LAMEA CELL-BASED ASSAY MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 54. LAMEA CELL-BASED ASSAY MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 55. BECTON DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 56. THERMO FISHER SCIENTIFIC, INC: COMPANY SNAPSHOT
TABLE 57. DANAHER CORPORATION: COMPANY SNAPSHOT
TABLE 58. GENERAL ELECTRIC COMPANY.: COMPANY SNAPSHOT
TABLE 59. MERCK KGAA: COMPANY SNAPSHOT
TABLE 60. PERKINELMER, INC: COMPANY SNAPSHOT
TABLE 61. BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 62. LONZA GROUP LTD: COMPANY SNAPSHOT
TABLE 63. CELL SIGNALING TECHNOLOGY, INC.: COMPANY SNAPSHOT
TABLE 64. PROMEGA CORPORATION: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 1. TOP INVESTMENT POCKETS: GLOBAL CELL-BASED ASSAY MARKET, BY APPLICATION (2016)
FIGURE 2. TOP WINNING STRATEGIES: NATURE AND TYPE (2015-2017)
FIGURE 3. TOP WINNING STRATEGIES: NATURE AND COMPANY (2015-2017)
FIGURE 4. PATENT ANALYSIS BY REGION
FIGURE 5. BARGAINING POWER OF BUYERS
FIGURE 6. BARGAINING POWER OF SUPPLIERS
FIGURE 7. THREAT OF NEW ENTRANTS
FIGURE 8. THREAT OF SUBSTITUTION
FIGURE 9. COMPETITIVE RIVALRY
FIGURE 10. MARKET SHARE ANALYSIS (2016)
FIGURE 11. CELL-BASED ASSAYMARKET: PRODUCT SEGMENATION
FIGURE 12. U.S. CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 13. CANADA CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 14. MEXICO CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 15. GERMANY CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 16. FRANCE CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 17. UK CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 18. ITALY CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 19. SPAIN CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 20. REST OF EUROPE CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 21. JAPAN CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 22. CHINA CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 23. AUSTRALIA CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 24. INDIA CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 25. SOUTH KOREA CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 26. TAIWAN CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 27. REST OF ASIA-PACIFIC CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 28. BRAZIL CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 29. TURKEY CELL-BASED ASSAY MARKET, 2016-20223 ($MILLION)
FIGURE 30. SAUDI ARABIA CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 31. REST OF LAMEA CELL-BASED ASSAY MARKET, 2016-2023 ($MILLION)
FIGURE 32. BECTON DICKINSON AND COMPANY: NET SALES, 2014-2017 ($MILLION)
FIGURE 33. BECTON DICKINSON AND COMPANY: REVENUE BY SEGMENT, 2015 (%)
FIGURE 34. THERMO FISHER SCIENTIFIC, INC: NET SALES, 2014-2017 ($MILLION)
FIGURE 35. THERMO FISHER SCIENTIFIC, INC: REVENUE BY SEGMENT, 2015 (%)
FIGURE 36. THERMO FISHER SCIENTIFIC, INC: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 37. DANAHER CORPORATION: NET SALES, 2014-2017 ($MILLION)
FIGURE 38. DANAHER CORPORATION: REVENUE BY SEGMENT, 2015 (%)
FIGURE 39. DANAHER CORPORATION: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 40. GENERAL ELECTRIC COMPANY.: NET SALES, 2014-2017 ($MILLION)
FIGURE 41. GENERAL ELECTRIC COMPANY.: REVENUE BY SEGMENT, 2015 (%)
FIGURE 42. GENERAL ELECTRIC COMPANY.: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 43. MERCK KGAA: NET SALES, 2014-2017 ($MILLION)
FIGURE 44. MERCK KGAA: REVENUE BY SEGMENT, 2015 (%)
FIGURE 45. MERCK KGAA: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 46. PERKINELMER, INC: NET SALES, 2014-2017 ($MILLION)
FIGURE 47. PERKINELMER, INC: REVENUE BY SEGMENT, 2015 (%)
FIGURE 48. PERKINELMER, INC: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 49. BIO-RAD LABORATORIES, INC.: NET SALES, 2014-2017 ($MILLION)
FIGURE 50. BIO-RAD LABORATORIES, INC.: REVENUE BY SEGMENT, 2015 (%)
FIGURE 51. BIO-RAD LABORATORIES, INC.: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 52. LONZA GROUP LTD: NET SALES, 2014-2017 ($MILLION)
FIGURE 53. LONZA GROUP LTD: REVENUE BY SEGMENT, 2015 (%)
FIGURE 54. LONZA GROUP LTD: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 55. PROMEGA CORPORATION: NET SALES, 2014-2017 ($MILLION)
FIGURE 56. PROMEGA CORPORATION: REVENUE BY SEGMENT, 2015 (%)
FIGURE 57. PROMEGA CORPORATION: REVENUE BY GEOGRAPHY, 2015 (%)